Hims & Hers Health: growth title in telemedicine with explosive revenue growth
Hims & Hers Health $HIMS is one of the fastest-growing stocks of 2024, with its expansion into the weight-loss injections (GLP-1) segment and aggressive marketing strategy driving its stock up 150%.
1. Rocketing revenue growth
- Q1: +46% | Q2: +52% | Q3: +72%
- Expected growth for Q4: up to 90%
-Demand...
Read more
- 25% is already a solid drop, but it may be a good time to buy.